Issue

Vol. 32 No. 3 (2020): Vol 32 Issue 3

Copyright (c) 2020 AJC

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Computational Study of Novel 2,3-Bis[(1-methyl-1H-imidazole-2-yl)sulfanyl]quinoxaline: Structural Aspects, Spectroscopic Investigation, HOMO-LUMO, MESP, NLO, ADMET Predictions and Molecular Docking Studies as Potential Biotin Carboxylase and Antibiotics R

https://doi.org/10.14233/ajchem.2020.22507
Ashutosh Kumar
Department of Chemistry, Faculty of Science, University of Lucknow, Lucknow-226007, India
https://orcid.org/0000-0001-8062-892X
Anjali Pandey
Department of Chemistry, Faculty of Science, University of Lucknow, Lucknow-226007, India
Anil Mishra
Department of Chemistry, Faculty of Science, University of Lucknow, Lucknow-226007, India
https://orcid.org/0000-0002-0276-6662

Corresponding Author(s) : Ashutosh Kumar

ashutosh.chemist@gmail.com

Asian Journal of Chemistry, Vol. 32 No. 3 (2020): Vol 32 Issue 3

Abstract

In this paper, a complete quantum chemical calculation has been done to describe the relevant structural aspects of novel 2,3-bis[(1-methyl-1H-imidazole-2-yl)sulfanyl]quinoxaline with combination of DFT/B3LYP method 6-311++G(d,p) basis set in gas phase and in solvent phase. The molecular structure was examined by using IR, 1H & 13C NMR and UV-visible techniques and solvent effect on spectroscopic properties are also discussed. The vibrational assignments are analyzed by PED using Gauss View 5.0 and VEDA 4.0 program. The 1H NMR and 13C NMR chemical shifts are calculated using the gauge-independent atomic orbital method (GIAO method) in gas phase and in solvents (water, DMSO and chloroform). The UV spectrum is calculated by using TD-DFT/6-311++G(d,p) method in gas phase and in solvent (water, DMSO and chloroform) using IEF-PCM model. With the help of theoretical calculations chemical activities, electrophilic/nucleophilic nature and sites in the molecule, molecular and chemical properties that cannot be obtained by experimental way are obtained. Accordingly, molecular electrostatic potential (MESP), hardness (η)/softness (S) parameters, net charges analyses are investigated to gain electrophilic and nucleophilic nature. Also the sites in molecule and Fukui function analysis are discussed. The dipole moment (μ), polarizability (αtot), anisotropic polarizability (Δα) and first-order hyperpolarizability (βtot) of the title compound are reported and results shows that the material is capable to generate non-linear effect (NLO). The in silico study of all the biological and ADMET properties of title molecule are also discussed and compared with reference drug ciprofloxacin antibiotics. The title molecule and reference drug ciprofloxacin docked with biotin carboxylase enzyme (PDB ID: 2V59) of E. coli and aminoglycoside phosphotransferase APH(2")IVA (PDB ID: 4DFU) of Enterococcus casseliflavus receptor with the help of Molegro molecular viewer 2.5 program and binding affinity (ΔG) were determined by ParDock server.

Keywords

Quinoxaline DFT calculations Spectroscopic properties Molecular docking NLO ADMET
Kumar, A., Pandey, A., & Mishra, A. (2020). Computational Study of Novel 2,3-Bis[(1-methyl-1H-imidazole-2-yl)sulfanyl]quinoxaline: Structural Aspects, Spectroscopic Investigation, HOMO-LUMO, MESP, NLO, ADMET Predictions and Molecular Docking Studies as Potential Biotin Carboxylase and Antibiotics R. Asian Journal of Chemistry, 32(3), 706–726. https://doi.org/10.14233/ajchem.2020.22507
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. H.W. Boucher, G.H. Talbot, J.S. Bradley, J.E. Edwards, D. Gilbert, L.B. Rice, M. Scheld, B. Spellberg and J. Bartlett, Clin. Infect. Dis., 48, 1 (2009); https://doi.org/10.1086/595011
  2. G. Taubes, Science, 321, 356 (2008); https://doi.org/10.1126/science.321.5887.356
  3. A.Y. Peleg and D.C. Hooper, N. Engl. J. Med., 362, 1804 (2010); https://doi.org/10.1056/NEJMra0904124
  4. R.J. Heath, S.W. White and C.O. Rock, Prog. Lipid Res., 40, 467 (2001); https://doi.org/10.1016/S0163-7827(01)00012-1
  5. J.W. Capbelll and J.E. Jr Cronan, Annu. Rev. Microbiol., 55, 305 (2001).
  6. Y.M. Zhang, S.W. White and C.O. Rock, J. Biol. Chem., 281, 17541 (2006); https://doi.org/10.1074/jbc.R600004200
  7. A. Kucers, S. Crowe, M.L. Grayson and J. Hoy, The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, and Antiviral Drugs, Butterworth Heinemann: Oxford, edn 5, pp. 452-457 (1997).
  8. J. Davies and G. Wright, Trends Microbiol., 5, 234 (1997); https://doi.org/10.1016/S0966-842X(97)01033-0
  9. T.C. Broussard, A.E. Price, S.M. Laborde and G.L. Waldrop, Biochemistry, 52, 3346 (2013); https://doi.org/10.1021/bi4000707
  10. A.K. Patidar, M. Jeyakandan, A.K. Mobiya and G. Selvam, Int. J. PharmTech Res., 3, 386 (2011).
  11. S. Au, J. Schacht and N. Weiner, Biomembranes, 862, 205 (1986); https://doi.org/10.1016/0005-2736(86)90484-0
  12. S.T. Nguyen, J.D. Williams, M.M. Butler, X. Ding, D.M. Mills, T.F. Tashjian, R.G. Panchal, S.K. Weir, C. Moon, H.O. Kim, J.A. Marsden, N.P. Peet and T.L. Bowlin, Bioorg. Med. Chem. Lett., 24, 3366 (2014); https://doi.org/10.1016/j.bmcl.2014.05.094
  13. R. Musiol, M. Serda, S.P. Hensel-Bielowka and J. Polanski, J. Curr. Med. Chem., 17, 1960 (2010); https://doi.org/10.2174/092986710791163966
  14. J.P. Kleim, R. Bender, U.M. Billhardt, C. Meichsner, G. Riess, M. Rosner, I. Winkler and A. Paessens, Antimicrob. Agents Chemother., 37, 1659 (1993); https://doi.org/10.1128/AAC.37.8.1659
  15. M. Suresh, P. Lavanya, D. Sudhakar, K. Vasu and C.V. Rao, J. Chem. Pharm. Res., 2, 497 (2010).
  16. V.K. Tandon, D.B. Yadav, H.K. Maurya, A.K. Chaturvedi and P.K. Shukla, Bioorg. Med. Chem., 14, 6120 (2006); https://doi.org/10.1016/j.bmc.2006.04.029.
  17. B. Zarranz, A.A. Jaso, I. Aldana and A. Monge, Bioorg. Med. Chem., 11, 2149 (2003); https://doi.org/10.1016/S0968-0896(03)00119-6.
  18. M.M. Badran, A.A. Moneer, H.M. Refaat and A.A. El-Malah, J. Chin. Chem. Soc., 54, 469 (2007); https://doi.org/10.1002/jccs.200700066.
  19. B. Solano, V. Junnotula, A. Marin, R. Villar, A. Burguete, E. Vicente, S. Perez-Silanes, I. Aldana, A. Monge, S. Dutta, U. Sarkar and K.S. Gates, J. Med. Chem., 50, 5485 (2007); https://doi.org/10.1021/jm0703993.
  20. G. Olayiwola, C.A. Obafemi and F.O. Taiwo, Afr. J. Biotechnol., 6, 777 (2007).
  21. A. Wadood, N. Ahmed, L. Shah, A. Ahmad, H. Hassan and S. Shams, Drug Des. Devel. Ther., 1, 3 (2013).
  22. E. Krovat, T. Steindl and T. Langer, Curr. Comp-Aid. Drug Des., 1, 93 (2005); https://doi.org/10.2174/1573409052952314.
  23. V. Alcolea, D. Plano, D.N. Karelia, J.A. Palop, S. Amin, C. Sanmartín and A.K. Sharma, Eur. J. Med. Chem., 113, 134 (2016); https://doi.org/10.1016/j.ejmech.2016.02.042.
  24. M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J.R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G.A. Petersson, H. Nakatsuji, M. Caricato, X. Li, H.P. Hratchian, A.F. Izmaylov, J. Bloino, G. Zheng, J.L. Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, J.A. Montgomery Jr., J.E. Peralta, F. Ogliaro, M. Bearpark, J.J. Heyd, E. Brothers, K.N. Kudin, V.N. Staroverov, R. Kobayashi, J. Normand, K. Raghavachari, A. Rendell, J.C. Burant, S.S. Iyengar, J. Tomasi, M. Cossi, N. Rega, J.M. Millam, M. Klene, J.E. Knox, J.B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R.E. Stratmann, O.
  25. Yazyev, A.J. Austin, R. Cammi, C. Pomelli, J.W. Ochterski, R.L. Martin, K. Morokuma, V.G. Zakrzewski, G.A. Voth, P. Salvador, J.J. Dannenberg, S. Dapprich, A.D. Daniels, Ö. Farkas, J.B. Foresman, J.V. Ortiz, J. Cioslowski and D.J. Fox, Gaussian, Inc., Wallingford CT (2009).
  26. K.R. Cousins, J. Am. Soc., 133, 8388 (2011); https://doi.org/10.1021/ja204075s
  27. E. Frich, H. P. Hratchian, R. D. Dennington II, T. A. Keith, John Millam, B. Nielsen, A. J. Holder, J. Hiscocks. Gaussian. Inc. GaussView Version 5.0.8 (2009).
  28. M.H. Jamroz, Vibrational Energy Distribution Analysis: VEDA 4 Program, Warsaw, Poland (2004).
  29. M.J. Frisch, J.A. Pople and J.S. Binkley, J. Chem. Phys., 80, 3265 (1984); https://doi.org/10.1063/1.447079
  30. R. Ditchfield, Mol. Phys., 27, 789 (1974); https://doi.org/10.1080/00268977400100711
  31. N.M. O’boyle, A.L. Tenderholt and K.M. Langner, J. Comput. Chem., 29, 839 (2008); https://doi.org/10.1002/jcc.20823
  32. A. Kumar, A. Pandey and A. Mishra, J. Biol. Chem. Res., 36, 1 (2019).
  33. A.D. Bochevarov, E. Harder, T.F. Hughes, J.R. Greenwood, D.A. Braden, D.M. Philipp, D. Rinaldo, M.D. Halls, J. Zhang and R.A. Friesner, Int. J. Quant. Chem., 113, 2110 (2013); https://doi.org/10.1002/qua.24481
  34. A. Pandey, A. Kumar and A. Mishra, J. Biol. Chem. Res., 36, 102 (2019).
  35. A. Pandey, A. Kumar and A. Mishra, Int. J. Sci. Res. Rev., 8, 2087 (2019). 35. http://www.molinspiration.com.
  36. http://www.acdlabs.com.
  37. http://www.swissadme.ch/index.php.
  38. http://preadmet.bmdrc.kr.
  39. www.molsoft.com/cgi-bin/msearch.cgi.
  40. http://tox.charite.de/protox_II/.
  41. http://www.rcsb.org/pdb.
  42. R. Thomsen and M.H. Christensen, J. Med. Chem., 49, 3315 (2006); https://doi.org/10.1021/jm051197e
  43. A. Gupta, P. Sharma and B. Jayaram, Protein Pept. Lett., 14, 632 (2007); https://doi.org/10.2174/092986607781483831
  44. I. Fleming, Frontier Orbitals and Organic Chemical Reactions, Wiley: London (1976).
  45. A.M. Asiri, M. Karabacak, M. Kurt and K.A. Alamry, Spectrochim. Acta A Mol. Biomol. Spectrosc., 82, 444 (2011); https://doi.org/10.1016/j.saa.2011.07.076
  46. B. Kosar and C. Albayrak, Spectrochim. Acta A Mol. Biomol. Spectrosc., 78, 160 (2011); https://doi.org/10.1016/j.saa.2010.09.016
  47. Y.N. Mabkhot, F.D. Aldawsari, S.S. Al-Showiman, A. Barakat, S.M. Soliman, M.I. Choudhary, S. Yousuf, M.S. Mubarak and T.B. Hadda, Chem. Cent. J., 9, 24 (2015); https://doi.org/10.1186/s13065-015-0100-9
  48. S. Suganthi, P. Balu, V. Sathyanarayanamoorthi, V. Kannappan, M. G. Mohamed Kamil, R. Kumar, J. Mol. Struct., 1108, 1 (2016); https://doi.org/10.1016/j.molstruc.2015.11.069
  49. R.G. Parr, L.V. Szentpaly and S. Liu, J. Am. Chem. Soc., 121, 1922 (1999); https://doi.org/10.1021/ja983494x
  50. O. Tamer, B. Sariboga and I. Uçar, Struct. Chem., 23, 659 (2012); https://doi.org/10.1007/s11224-011-9910-0
  51. E. Scrocco and J. Tomasi, Adv. Quantum Chem., 11, 115 (1978); https://doi.org/10.1016/S0065-3276(08)60236-1
  52. F.J. Luque, J.M. Lopez and M. Orozco, Theor. Chem. Acc., 103, 343 (2000); https://doi.org/10.1007/s002149900013
  53. G. Schneider, Prediction of Drug-Like Properties, In: Madame Curie Bioscience Database, Landes Bioscience: Austin (TX) (2000-2013).
  54. J.C. Adams, M.J. Keiser, L. Basuino, H.F. Chambers, D.-S. Lee, O.G. Wiest and P.C. Babbitt PLoS Comput. Biol., 5, e1000474 (2009) https://doi.org/10.1371/journal.pcbi.1000474
  55. J.M. Seminario, Molecular Electrostatic Potentials, Concepts and Applications, Elsevier: Amsterdam (1996).
  56. P.W. Ayers and R.G. Parr, J. Am. Chem. Soc., 122, 2010 (2000); https://doi.org/10.1021/ja9924039
  57. R.G. Parr and W.J. Yang, Am. Chem. Soc., 106, 4049 (1984); https://doi.org/10.1021/ja00326a036
  58. W. Yang and W.J.J. Mortier, J. Am. Chem. Soc., 108, 5708 (1986); https://doi.org/10.1021/ja00279a008
  59. R.K. Roy, S. Krishnamurti, P. Geerlings and S. Pal, J. Phys. Chem. A, 102, 3746 (1998); https://doi.org/10.1021/jp973450v
  60. P.K. Chattaraj, B. Maiti and U. Sarkar, J. Phys. Chem. A, 107, 4973 (2003); https://doi.org/10.1021/jp034707u
  61. M. Govindarajan, M. Karabacak, S. Periandy and D. Tanuja, Spectrochim. Acta A Mol. Biomol. Spectrosc., 97, 231 (2012); https://doi.org/10.1016/j.saa.2012.06.014
  62. R.S. Mulliken, J. Chem. Phys., 23, 1833 (1955); https://doi.org/10.1063/1.1740588
  63. E.R. Davidson and S. Chakravorty, Theor. Chim. Acta, 83, 319 (1992); https://doi.org/10.1007/BF01113058
  64. M.D. Segall, C.J. Pickard, R. Shah and M.C. Payne, Mol. Phys., 89, 571 (1996); https://doi.org/10.1080/002689796173912
  65. R.M. Silverstein, G.C. Basseler and C. Morill, Spectroscopic Identification of Organic Compounds, Wiley, New York (1981).
  66. R. Shunmugam and D.N. Sathyanarayana, Spectrochim. Acta A Mol.. Spectrosc., 40, 757 (1984); https://doi.org/10.1016/0584-8539(84)80100-2
  67. A.R. Prabhakaran and S. Mohan, Indian J. Phys., 63B, 468 (1989).
  68. R.M. Silverstein, F.X. Webster and D. Kiemle, Spectrometric Identification of Organic Compounds, John Wiley & ons Inc., edn 2 (2005).
  69. M. Karabacak, C. Karaca, A. Atac, M. Eskici, A. Karanfil and E. Kose, Spectrochim. Acta A Mol. Biomol. Spectrosc., 97, 556 (2012); https://doi.org/10.1016/j.saa.2012.05.087
  70. D. Sajan, H. Joe, V.S. Jayakumar and J. Zaleski, J. Mol. Struct., 785, 43 (2006); https://doi.org/10.1016/j.molstruc.2005.09.041
  71. V.M. Geskin, C. Lambert and J.-L. Brédas, J. Am. Chem. Soc., 125, 15651 (2003); https://doi.org/10.1021/ja035862p
  72. R. Zhang, B. Du, G. Sun and Y. Sun, Spectrochim. Acta A Mol. Biomol. Spectrosc., 75, 1115 (2010); https://doi.org/10.1016/j.saa.2009.12.067
  73. A. Verma, Asian Pac. J. Trop. Biomed., 2, S1735 (2012); https://doi.org/10.1016/S2221-1691(12)60486-9
  74. C.A. Lipinski, F. Lombardo, B.W. Dominy and P.J. Feeney, Adv. Drug Deliv. Rev., 46, 3 (2001); https://doi.org/10.1016/S0169-409X(00)00129-0
  75. P. Ertl, B. Rohde and P. Selzer, J. Med. Chem., 43, 3714 (2000); https://doi.org/10.1021/jm000942e
  76. N. Roy and R.U. Kadam, Indian J. Pharm. Sci., 69, 609 (2007); https://doi.org/10.4103/0250-474X.38464
  77. A.K. Ghose, T. Herbertz, R.L. Hudkins, B.D. Dorsey and J.P. Mallamo, ACS Chem. Neurosci., 3, 50 (2012); https://doi.org/10.1021/cn200100h
  78. D.E. Pires, T.L. Blundell and D.B. Ascher, J. Med. Chem., 58, 4066 (2015); https://doi.org/10.1021/acs.jmedchem.5b00104
  79. A. Daina and V. Zoete, ChemMedChem, 11, 1117 (2016); https://doi.org/10.1002/cmdc.201600182
  80. F. Yamashita and M. Hashida, Drug. Metab. Pharm., 19, 327 (2004); https://doi.org/10.2133/dmpk.19.327
  81. F.J. Azeredo, F.T. Uchoa and T.D. Costa, Rev. Bras. Farm., 90, 321 (2009).
  82. B.N. Ames, E.G. Gurney, J.A. Miller and H. Bartsch, Proc. Natl. Acad. Sci. USA, 69, 3128 (1972); https://doi.org/10.1073/pnas.69.11.3128
  83. M.N. Drwal, P. Banerjee, M. Dunkel, M.R. Wettig and R. Preissner, Nucleic Acids Res., 42(W1), W53 (2014); https://doi.org/10.1093/nar/gku401
  84. F. Ntie-Kang, L.L. Lifongo, J.A. Mbah, L.C. Owono Owono, E. Megnassan, L.M. Mbaze, P.N. Judson, W. Sippl and S.M.N. Efange, In Silico Pharmacol., 1, 12 (2013); https://doi.org/10.1186/2193-9616-1-12
  85. J.R. Miller, S. Dunham, I. Mochalkin, C. Banotai, M. Bowman, S. Buist, B. Dunkle, D. Hanna, H.J. Harwood, M.D. Huband, A. Karnovsky, M. Kuhn, C. Limberakis, J.Y. Liu, S. Mehrens, W.T. Mueller, L. Narasimhan, A. Ogden, J. Ohren, J.V.N.V. Prasad, J.A. Shelly, L. Skerlos, M. Sulavik, V.H. Thomas, S. Vander Roest, L.A. Wang, Z. Wang, A. Whitton, T. Zhu and C.K. Stover, Proc. Natl. Acad. Sci. USA, 106, 1737 (2009); https://doi.org/10.1073/pnas.0811275106
  86. S. Velankar, P. McNeil, V. Mittard-Runte, A. Suarez, D. Barrell, R. Apweiler and K. Henrick, Nucleic Acids Res., 33, D262 (2004); https://doi.org/10.1093/nar/gki058
Read More
Author biographies is not available.
Download
PDF
Statistic
Read Counter : 0 Download : 0